Concepedia

Author

Robin T. Vollmer

Duke Medical Center

Also Known As

R T Vollmer, ROBIN T. VOLLMER, ROBIN T. VOLLMER, Robin T Vollmer, Robin T. Vollmer, Robin T. Vollmer, MD, Robin T. Vollmer, MD, MS, Robin Vollmer, Robin Vollmer, MD, Switzer, Boyd R.

246

Publications

12.1K

Citations

57

H-Index

141

Concepts

All Affiliations

Duke Medical CenterDuke University HospitalDurham VA Medical CenterDuke UniversityWashington University in St. Louis
RT

About

Robin T. Vollmer is an author at Duke Medical Center specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

39

80

6.2K

2

Health Sciences

12

12

1.4K

3

Engineering

5

5

300

4

Anatomy

5

5

597

5

Public Health

4

4

296

Robin T. Vollmer

×

142

Publications

11.4K

Citations

56

H-Index

YearCitations

Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

Glenn J. Bubley, Michael A. Carducci, William L. Dahut,

Journal of Clinical Oncology

1999

979

Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx:

Stephanie L. Wain, Ruben Kier, Robin T. Vollmer,

Human Pathology

1986

483

Theory and Practice of Histological Techniques

Robin T. Vollmer

JAMA

1983

358

Vitamin D and prostate cancer: a prediagnostic study with stored sera.

Elizabeth H. Corder, Harry A. Guess, Barbara S. Hulka,

PubMed

1993

356

Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer

Lionel L. Bañez, Robert J. Hamilton, Alan W. Partin,

JAMA

2007

353

Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.

Peter A. Humphrey, Xiaopei Zhu, Reza Zarnegar,

PubMed

1995

332

Gefitinib in Patients with Malignant Mesothelioma: A Phase II Study by the Cancer and Leukemia Group B

Ramaswamy Govindan, Robert A. Kratzke, James E. Herndon,

Clinical Cancer Research

2005

256

Lung cancer heterogeneity: A blinded and randomized study of 100 consecutive cases

Victor L. Roggli, Robin T. Vollmer, S. Donald Greenberg,

Human Pathology

1985

234

Interferon alfa-2a in the treatment of cutaneous T cell lymphoma

Elise A. Olsen, Steven T. Rosen, Robin T. Vollmer,

Journal of the American Academy of Dermatology

1989

227

Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features

Wendy Demark‐Wahnefried, David T. Price, Thomas J. Polascik,

Urology

2001

218

Page 1